Given the fact that the PI3K-AKT-mTOR pathway plays a critical role in controlling pro-survival cellular signals, it is possible that cancer cells, under therapeutic pressures, adaptively hyperactivate the pathway and its downstream cascades to compensate/overcome cellular stress. This evidence concerns the gene AKT1 and cancer.